Publication date: Jul 23, 2024
Antimicrobial resistance (AMR) occurs when microorganisms (bacteria, viruses, fungi and parasites) no longer respond to antimicrobials, rendering these specific treatments ineffective. Subsequently, this narrows the options for clinical treatment and increases the risk of complications, hospital admissions, and mortality rates. Ultimately, infections become more difficult to treat. The concern of AMR is not new, yet the COVID-19 pandemic has further highlighted this global burden and raised questions regarding the preparedness for the fight against increasing cases of AMR. In a joint collaboration, Nature Communications, Nature Microbiology, Nature Medicine, Communications Medicine and Scientific Reports have launched a Collection and call for papers, inviting submissions of papers that advance our understanding of all aspects of AMR, as outlined in the Collection scope.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Fungi | Anti-Bacterial Agents |
| Medicine | Anti-Bacterial Agents |
| Microbiology | Drug Resistance, Bacterial |
| New | Humans |
| Parasites | Pandemics |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | Bacteria |
| disease | VO | Viruses |
| disease | VO | Fungi |
| disease | VO | ineffective |
| disease | MESH | complications |
| disease | MESH | infections |
| disease | MESH | COVID-19 pandemic |
| drug | DRUGBANK | Trestolone |
| disease | IDO | country |
| disease | VO | LACK |
| drug | DRUGBANK | Water |
| disease | IDO | infection |
| drug | DRUGBANK | Spinosad |
| disease | VO | organ |
| disease | MESH | bacterial infections |
| disease | VO | effective |
| drug | DRUGBANK | Coenzyme M |
| disease | VO | vaccine |
| disease | VO | organization |
| disease | VO | report |